NFKB1 and neoplasm: Elevated UGCG expression has been associated with enhanced activity of downstream effectors, including nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and the canonical Wnt pathway (Wnt/β-catenin), which are known to promote tumor progression.